Description
Cereglya (Choline Alfoscerate) Soft Capsules 400 mg. №30
Composition
The active ingredient in Cereglya is choline alfoscerate, a naturally occurring substance that supports brain health. Each soft capsule contains 400 mg of choline alfoscerate.
Mechanism of Action
Choline alfoscerate acts as a precursor to acetylcholine, a neurotransmitter involved in cognitive function. It supports neuronal membrane integrity and function, enhancing neurotransmission and promoting overall brain health.
Pharmacological Properties
Cereglya exerts its pharmacological effects by increasing choline availability in the brain, thereby enhancing cholinergic neurotransmission. It also supports phospholipid synthesis and repair, contributing to neuronal membrane stability and function.
Indications for Use
Cereglya is indicated for the treatment of cognitive disorders associated with neurodegenerative and vascular diseases. It is beneficial in managing symptoms of Alzheimer’s disease, stroke, and dementia, helping to improve cognitive function and quality of life in affected individuals.
Contraindications
Cereglya is contraindicated in patients with known hypersensitivity to choline alfoscerate or any other ingredient in the product. It is also not recommended for use in pregnant or breastfeeding women without medical advice, due to potential risks to the fetus or infant.
Side Effects
Common side effects of Cereglya may include gastrointestinal disturbances such as nausea, diarrhea, or abdominal discomfort. In rare cases, hypersensitivity reactions like rash or itching may occur. If any adverse effects persist or worsen, discontinue use and consult a healthcare provider.
Usage Instructions
For optimal results, take one Cereglya capsule three times daily with meals. Swallow the capsules whole with a glass of water to ensure proper absorption. If a dose is missed, take it as soon as possible, unless it is close to the next scheduled dose. Avoid doubling the dose to prevent potential side effects.
Benefits Compared to Analogues
Cereglya offers a unique formulation of choline alfoscerate, providing targeted support for cognitive function and brain health. Its specific mechanism of action sets it apart from other cognitive enhancers, offering a comprehensive approach to managing cognitive disorders associated with neurodegenerative conditions.
Suitable Patient Groups
Cereglya is suitable for adult patients experiencing cognitive decline due to neurodegenerative or vascular diseases. It is not recommended for use in children or adolescents without medical supervision. Elderly individuals may benefit from Cereglya’s neuroprotective properties and cognitive enhancement effects.
Storage and Shelf Life
Store Cereglya in a cool, dry place away from direct sunlight and moisture. Ensure the product is kept out of reach of children and pets. Check the expiration date on the packaging and do not use the product if past the specified shelf life.
Packaging Description
Cereglya is available in packs containing 30 soft capsules, each labeled with the product name and dosage strength. The packaging is designed to maintain the integrity and stability of the capsules, protecting them from environmental factors that may affect their quality.
